MTAs with Industry
Exchange of materials to and from industry is managed on a case-by-case basis. When negotiating acceptable terms, the office of biotechnology’s role in the process is to ensure that MTAs are in compliance with Einstein and NIH policy, as well as our legal obligations. It is our intent to protect the best interests of both, Einstein and our faculty inventors in these negotations.
Industry MTAs must be reviewed by the office of biotechnology and should be directed to:
Outgoing MTAs and Research License Agreements
Specifically, outgoing MTAs involve situations in which Einstein provides materials to nonprofit or commercial entities that request them.
These agreements to transfer materials to industry are negotiated on a case-by-case basis and are designed to reflect the nature of the intended use of the materials by the recipient. The intended uses may vary and may include such purposes as internal research, manufacturing, quality control, sale of the research reagent or application in performance of a service. In some instances a Material Transfer Agreement is the appropriate agreement with which to transfer material, and in other instances a license or another agreement is the appropriate method for transferring material. To determine the most appropriate agreement for a given situation, the recipient is asked to provide the following information:
- How will the recipient use the material (internal research, manufacturing, sale of a product/service or other use)?
- For what purpose does the recipient wish to use the material?
- If the material is being used for internal research, does the recipient anticipate needing the material for any other purpose after the research is completed? If so, for what other purpose does the recipient wish to use the material?
- For how long will the recipient need the material?
- At which sites will the material be used?
- How much material will the recipient need?
Material Transfer Agreements and other licenses involving industry are generally granted on a nonexclusive basis to the recipient and are subject to the payment of license fees. All income generated from such licenses are distributed in accordance with the Patent Policy. All requests from industry for materials made at Einstein should be referred to the office of biotechnology at email@example.com.
Additionally, please note that the office of business development has launched its Agent Reagent Program, in which it is proactively marketing Einstein research tools to industry partners.